PATENT CLAIM ANALYSIS

Application Number: 16158065
Application Type: Utility
Filing Date: 2018-10
Publication Date: 2019-04
Patent Classification: ["435", "006100"]

Abstract:
The present invention is in the field of hematological diseases of carcinogenic origin. More specifically, the present invention relates to the use of Wiscott-Aldrich syndrome protein (WASP) as a biological marker of the progression of a hematological disease, in particular leukemias, and to an in vitro method for monitoring the progression of a hematological disease, such as leukemia.

Claim (Index 9):
The method of  claim 8 , wherein the amount of WASP is determined by qRT-PCR.

Metadata:
- Claim Count in Document: 26.0
- Percentile: 97.0
- Lexical Diversity: 1.60976
- Patent Class: 435.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['13122137', '12875025', '10579540', '15308673', '14354822']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.6054515062463215
- 35 USC 102 Novelty (BERT): 0.5346214329966437
- Combined Prediction Score: 0.5983684989213537
- Mean Citation Score: 318.1413960000001
- Max Citation Score: 328.1286
- Similarity Product: 163.08301703578238

Labels:
- Claim Label 101: 0
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 0
- Label 101 Adjusted: 0

Dataset: test